Anxiety Disorders in General Practice
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Anxiety disorders are a variant of borderline mental pathology belonging to the group of neurotic disorders, that is, to psychogenically caused by painful conditions characterized by a variety of clinical manifestations. Timely diagnosis and early start of adequate treatment of anxiety spectrum disorders can significantly improve the quality of life of patients.
The article discusses the phenomenological aspects of anxiety disorders, especially the diagnosis and treatment in the general medical network, in particular, the currently recommended regimens for using the drug Eglonil and the advantages of this drug are described. Eglonil demonstrates the possibility of widespread use in various types of anxiety disorders, which gives the drug a special status among other psychotropic compounds.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Васюк Ю.А., Довженко Т.В., Школьник Е.Л., Ющук Е.В. Депрессия и хроническая сердечная недостаточность при сердечно-сосудистых заболеваниях. – М., 2008.
Дзяк Л.А., Цуракаленко Е.С. Тревожные расстройства в общей медицинской практике // Семейная медицина. – 2016. – № 5 (67). – С. 55–59.
Иванов С.В. Тревожные расстройства в общей медицине (клиника, фармакотерапия) // Психиатрия и психофармакотерапия. – 2013. – № 15 (4). – С. 40–44.
Смулевич А.Б., Дробижев М.Ю., Иванов С.В. Транквилизаторы, производные бензодиазепина в психиатрии, психосоматике и общей медицине. – М., 2005.
Смулевич А.Б. Психические расстройства в клинической практике. – М., 2011.
Чугунов Д.А., and Шмилович А.А. Трудности диагностики и особенности терапии тревожно-фобических расстройств в условиях психиатрического стационара // Современная терапия в психиатрии и неврологии, 2017. – № 3. С. 4–12.
American Psychiatric Association. Cautionary statement for forensic use of DSM-5. In Diagnostic and statistical manual of mental disorders (5th ed.), 2013. https://doi.org/10.1176/appi.books.9780890425596
Anxiety disorders. Quality standard [QS53], NICE 2014. https://www.nice.org.uk/guidance/qs53/chapter/Quality-statement-3-Pharmacological-treatment
Baxter A.J., Scott K.M., Vos T., Whiteford H.A. Global prevalence of anxiety disorders: a systematic review and metaregression // Psychological Medicine 2013; 43 (5): 897–910. https://doi.org/10.1017/S003329171200147X
Baxter A.J., Vos T., Scott K.M. et al. The global burden of anxiety disorders in 2010. Psychol. Med., 2014, 44(11): 2363–2374. https://doi.org/10.1017/S0033291713003243
Bell C., Bhikha S., Colhoun H., Carter F., Frampton C., Porter R. The response to sulpiride in social anxiety disorder: D2 receptor function. Journal of Psychopharmacology, 2012, Vol 27, Issue 2, pp. 146–151 https://doi.org/10.1177/0269881112450778
Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults, AAFP 2015. https://www.aafp.org/afp/2015/0501/p617.html
Mackenzie C.S., Reynolds K., Cairney J., Streiner D.L., Sareen J. Disorderspecific mental health service use for mood and anxiety disorders: associations with age, sex, and psychiatric comorbidity // Depression and Anxiety 2012; 29(3): 234–242. https://doi.org/10.1002/da.20911
Perna G., Alciaty A., Riva A. et al. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review. Curr. Psychiatry Rep., 2016, 18: 23. https://doi.org/10.1007/s11920-016-0668-3
Practical Guideline for the treatment of patients with panic disorders, APA 2009. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf
Screening and Correlates of Neurotic Disorders Among General Medical Outpatients in Xi’an China / C. Ni [et al.] // Perspect. Psychiatr. Care 2015; 51(2): 128–35. https://doi.org/10.1111/ppc.12074
Yapici Eser H, Kacar AS, Kilciksiz CM, Yalçinay-Inan M, Ongur D. Prevalence and Associated Features of Anxiety Disorder Comorbidity in Bipolar Disorder: A Meta-Analysis and Meta-Regression Study. Frontiers in Psychiatry. 2018;9:229. https://doi.org/10.3389/fpsyt.2018.00229
